These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37100194)

  • 21. High-throughput sequencing of the T-cell receptor β chain gene distinguishes 2 subgroups of cutaneous T-cell lymphoma.
    Wang J; Rea B; Haun P; Emerson R; Kirsch I; Bagg A
    J Am Acad Dermatol; 2019 Apr; 80(4):1148-1150.e1. PubMed ID: 30365996
    [No Abstract]   [Full Text] [Related]  

  • 22. Cutaneous extranodal NK/T-cell lymphoma: a clinicopathologic study of 5 patients with array-based comparative genomic hybridization.
    Berti E; Recalcati S; Girgenti V; Fanoni D; Venegoni L; Vezzoli P
    Blood; 2010 Jul; 116(2):165-70. PubMed ID: 20404131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cutaneous gamma/delta T-cell lymphoma.
    Koch R; Jaffe ES; Mensing C; Zeis M; Schmitz N; Sander CA
    J Dtsch Dermatol Ges; 2009 Dec; 7(12):1065-7. PubMed ID: 19694889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular staging of cutaneous T-cell lymphoma: evidence for systemic involvement in early disease.
    Veelken H; Wood GS; Sklar J
    J Invest Dermatol; 1995 Jun; 104(6):889-94. PubMed ID: 7769255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunophenotypic shift of CD4 and CD8 antigen expression in primary cutaneous T-cell lymphomas: a clinicopathologic study of three cases.
    Aung PP; Climent F; Muzzafar T; Curry JL; Patel KP; Servitje O; Prieto VG; Duvic M; Jaffe ES; Torres-Cabala CA
    J Cutan Pathol; 2014 Jan; 41(1):51-7. PubMed ID: 24151865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeted genomic analysis of cutaneous T cell lymphomas identifies a subset with aggressive clinicopathological features.
    Argyropoulos KV; Pulitzer M; Maura F; Mohanty A; Mondello P; Horwitz SM; Myskowski P; Moskowitz A; Dogan A; Querfeld C; Rapaport F; Siakantaris M; Louis PC; Galasso N; van den Brink MRM; Palomba ML
    Blood Cancer J; 2020 Nov; 10(11):116. PubMed ID: 33168809
    [No Abstract]   [Full Text] [Related]  

  • 27. Epigenetics of Cutaneous T-Cell Lymphomas.
    Hara N; Sawada Y
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The protean spectrum of non-Hodgkin lymphomas with prominent involvement of subcutaneous fat.
    Massone C; Lozzi GP; Egberts F; Fink-Puches R; Cota C; Kerl H; Cerroni L
    J Cutan Pathol; 2006 Jun; 33(6):418-25. PubMed ID: 16776717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of BCL7A expression correlates with poor disease prognosis in patients with early-stage cutaneous T-cell lymphoma.
    Litvinov IV; Zhou Y; Kupper TS; Sasseville D
    Leuk Lymphoma; 2013 Mar; 54(3):653-4. PubMed ID: 22856870
    [No Abstract]   [Full Text] [Related]  

  • 30. The role of molecular analysis in cutaneous lymphomas.
    Deonizio JM; Guitart J
    Semin Cutan Med Surg; 2012 Dec; 31(4):234-40. PubMed ID: 23174493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [New aspects in the classification of cutaneous lymphomas].
    Erós N; Károlyi Z; Kovács A
    Orv Hetil; 2001 Feb; 142(8):393-8. PubMed ID: 11263077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequent beta-catenin overexpression without exon 3 mutation in cutaneous lymphomas.
    Bellei B; Pacchiarotti A; Perez M; Faraggiana T
    Mod Pathol; 2004 Oct; 17(10):1275-81. PubMed ID: 15195109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cutaneous natural killer/T-cell lymphoma.
    Radonich MA; Lazova R; Bolognia J
    J Am Acad Dermatol; 2002 Mar; 46(3):451-6. PubMed ID: 11862188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High expression of Dicer reveals a negative prognostic influence in certain subtypes of primary cutaneous T cell lymphomas.
    Valencak J; Schmid K; Trautinger F; Wallnöfer W; Muellauer L; Soleiman A; Knobler R; Haitel A; Pehamberger H; Raderer M
    J Dermatol Sci; 2011 Dec; 64(3):185-90. PubMed ID: 21937200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary cutaneous T-cell lymphoma, unspecified, exhibiting an aggressive clinical course and a cytotoxic phenotype.
    Yamamoto M; Nakada T; Iijima M
    Int J Dermatol; 2008 Jul; 47(7):720-2. PubMed ID: 18613882
    [No Abstract]   [Full Text] [Related]  

  • 36. Pathology of cutaneous T-cell lymphoma.
    Burg G; Dummer R; Dommann S; Nestle F; Nickoloff B
    Hematol Oncol Clin North Am; 1995 Oct; 9(5):961-95. PubMed ID: 8522491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymphocytes from patients with cutaneous T-cell lymphoma show DNA instability and reduced DNA repair using the Comet assay.
    Thestrup-Pedersen K; Wang C
    J Eur Acad Dermatol Venereol; 2017 May; 31(5):e224-e225. PubMed ID: 27878874
    [No Abstract]   [Full Text] [Related]  

  • 38. Challenging Cutaneous T-Cell Lymphoma: What Animal Models Tell us So Far.
    Bresin A; Caprini E; Russo G; Narducci MG
    J Invest Dermatol; 2022 Jun; 142(6):1533-1540. PubMed ID: 35000751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unusual cutaneous lymphomas.
    Perniciaro C
    Dermatol Surg; 1996 Mar; 22(3):288-92. PubMed ID: 8599741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of Epstein-Barr virus genes in malignant lymphoma with clinical and histologic features of cytophagic histiocytic panniculitis.
    Harada H; Iwatsuki K; Kaneko F
    J Am Acad Dermatol; 1994 Aug; 31(2 Pt 2):379-83. PubMed ID: 8034809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.